Evidence map›Paper›PMID 31637963›Full record

SynthesisMultiple sclerosis (Houndmills, Basingstoke, England)2019

Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Curtis M Wojcik, Meghan Beier, Kathleen Costello, John DeLuca, Anthony Feinstein, Yael Goverover, Mark Gudesblatt, Michael Jaworski, Rosalind Kalb, Lori Kostich and 4 more

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Multiple sclerosis (Houndmills, Basingstoke, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04604041 (Investigation of Subclinical Markers of Multiple Sclerosis), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04604041 recruitingnot on this mapstarted 2020, after this paper: background citation

Investigation of Subclinical Markers of Multiple Sclerosis

TypeobservationalSponsorUniversity of Split, School of MedicineRan2020 to 2028Enrolled50ConditionsMultiple Sclerosis, Relapsing Remitting Multiple SclerosisArms1. Clinical testing, 2. Neurophysiological examination (TMS, EMNG), 3. Psychomotor examination, 4. Neuropsychological evaluation, 5. Flow cytometry
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Plateau of practice effects and noise with repeat SDMT testing in multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2025
    Article
  10. Article
  11. Article
  12. Neuropsychological assessment in MS is outdated and in need for innovation: NO.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Article
  13. Computerized Cognitive Test Batteries for Children and Adolescents-A Scoping Review of Tools For Lab- and Web-Based Settings From 2000 to 2021.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. A validation study for remote testing of cognitive function in multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Curtis M WojcikJacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Meghan BeierDivision of Rehabilitation Psychology and Neuropsychology, Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kathleen CostelloNational Multiple Sclerosis Society, New York, NY, USA.
John DeLucaDepartment of Physical Medicine and Rehabilitation and Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, USA.
Anthony FeinsteinDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.
Yael GoveroverNew York University, New York, NY, USA/South Shore Neurologic Associates, New York, NY, USA.
Mark GudesblattSouth Shore Neurologic Associates Islip, NY.
Michael JaworskiJacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Rosalind KalbNational Multiple Sclerosis Society, New York, NY, USA.
Lori KostichThe Mandell MS Center, Mount Sinai Rehabilitation Hospital, Hartford, CT, USA.
Nicholas G LaRoccaNational Multiple Sclerosis Society, New York, NY, USA.
Jonathan D RodgersJacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA/Jacobs Neurological Institute, Buffalo, NY, USA/Canisius College, Buffalo, NY, USA.
Ralph Hb BenedictJacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA/Jacobs Neurological Institute, Buffalo, NY, USA.
National MS Society Cognition Work Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe proliferation of computerized neuropsychological assessment devices (CNADs) for screening and monitoring cognitive impairment is increasing exponentially. Previous reviews of computerized tests for multiple sclerosis (MS) were primarily qualitative and did not rigorously compare CNADs on psychometric properties.

objectiveWe aimed to systematically review the literature on the use of CNADs in MS and identify test batteries and single tests with good evidence for reliability and validity.

methodA search of four major online databases was conducted for publications related to computerized testing and MS. Test-retest reliability and validity coefficients and effect sizes were recorded for each CNAD test, along with administration characteristics.

resultsWe identified 11 batteries and 33 individual tests from 120 peer-reviewed articles meeting the inclusion criteria. CNADs with the strongest psychometric support include the CogState Brief Battery, Cognitive Drug Research Battery, NeuroTrax, CNS-Vital Signs, and computer-based administrations of the Symbol Digit Modalities Test.

conclusionWe identified several CNADs that are valid to screen for MS-related cognitive impairment, or to supplement full, conventional neuropsychological assessment. The necessity of testing with a technician, and in a controlled clinic/laboratory environment, remains uncertain.

Indexed as

Diagnosis, Computer-AssistedNeuropsychological TestsCognition DisordersHumansMultiple SclerosisReproducibility of Resultscognitioncomputerized testsMultiple sclerosisreliabilitysystematic reviewvalidity

Identifiers

PMID31637963
PMCPMC6875828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.